FindTrial
Sign In

An exploratory study of benvimoder cream in the treatment of palmoplantar pustulosis

An exploratory study of benvimoder cream in the treatment of palmoplantar pustulosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047455
Enrollment
Unknown
Registered
2021-06-18
Start date
2021-06-15
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pustulosis palmaris plantaris

Interventions

Experimental group:Benvimoder cream
Control group:Halometasone Cream

Sponsors

Beijing You'an Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years; 2. The diagnosis of palmoplantar pustulosis was clear; 3. The distribution of lesions in both hands (feet) was basically symmetrical; 4. No oral or topical drugs were used in the past 2 weeks; 5. There was good compliance and regular follow-up for 3 months.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactation; 2. Suffering from serious systemic diseases; 3. Those who can't use drugs according to regulations and follow up regularly; 4. Allergic to the components of the study drug or control drug.

Design outcomes

Primary

MeasureTime frame
Dermatological quality of life index score;Clinical symptoms and signs were graded by 4 grades;—

Countries

China

Contacts

Public ContactZhang Ming

Beijing You'an Hospital Affiliated to Capital Medical University

yayyzhming@126.com+86 15801090639

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026